What does the evidence say about Shilajit Fatigue Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Shilajit Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background: Exercise and nutritional interventions are often recommended to help manage risk related to metabolic syndrome (MetSyn). [Martinez V (2025); evidence level 2] - This study evaluated whether dietary supplementation with Cr, PE, and SJ, or PE alone, during an exercise and diet intervention may help individuals with risk factors to MetSyn experience greater benefits. [Martinez V (2025); evidence level 2] - Results : Compared to PLA responses, there was some evidence ( p p > 0.05 to p Conclusions : The results suggest that PE and Cr with PE and SJ supplementation may enhance some exercise- and diet-induced changes in markers of health in overweight individuals with at least two risk factors to MetSyn. [Martinez V (2025); evidence level 2] - The co-ingestion of Phyllanthus emblica (PE) with trivalent chromium (Cr) has been purported to improve the bioavailability of chromium and enhance endothelial function, reduce platelet aggregation, and help manage blood glucose as well as lipid levels. [Martinez V (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.